LABD:ARCA-Direxion Daily S&P Biotech Bear 3X Shares (USD)

ETF | Trading--Inverse Equity | NYSE Arca

Last Closing

USD 5.52

Change

+0.04 (+0.73)%

Market Cap

USD 0.10B

Volume

0.02B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index. The index includes domestic companies from the biotechnology industry. The fund is non-diversified.

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.55%

Management Expense Ratio: 1.00 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SH ProShares Short S&P500 0.89 %

+0.04 (+0.36%)

USD 1.03B
SOXS Direxion Daily Semiconductor B.. 0.97 %

+0.77 (+3.19%)

USD 0.75B
PSQ ProShares Short QQQ 0.95 %

+0.20 (+0.48%)

USD 0.74B
SPXU ProShares UltraPro Short S&P50.. 0.91 %

+0.27 (+1.03%)

USD 0.52B
SDOW ProShares UltraPro Short Dow30 0.95 %

+0.12 (+0.86%)

USD 0.32B
SPDN Direxion Daily S&P 500® Bear .. 0.45 %

+0.05 (+0.43%)

USD 0.18B
DOG ProShares Short Dow30 0.95 %

+0.09 (+0.33%)

USD 0.17B
RWM ProShares Short Russell2000 0.95 %

N/A

USD 0.16B
YANG Direxion Daily FTSE China Bear.. 1.02 %

+0.13 (+1.56%)

USD 0.11B
FNGD MicroSectors FANG+ Index -3X I.. 0.00 %

+0.38 (+1.64%)

USD 0.11B

ETFs Containing LABD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -43.03% 13% F 4% F
Dividend Return 1.60% 25% F 37% F
Total Return -41.43% 13% F 4% F
Trailing 12 Months  
Capital Gain -69.97% 7% C- 2% F
Dividend Return 1.31% 4% F 18% F
Total Return -68.66% 7% C- 2% F
Trailing 5 Years  
Capital Gain -98.63% 9% A- 1% F
Dividend Return 0.55% 8% B- 2% F
Total Return -98.08% 9% A- 1% F
Average Annual (5 Year Horizon)  
Capital Gain 61.37% 68% D+ 96% N/A
Dividend Return 62.20% 68% D+ 96% N/A
Total Return 0.82% 17% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 1,067.44% 30% F 1% F
Risk Adjusted Return 5.83% 61% D- 29% F
Market Capitalization 0.10B 56% F 27% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.